Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Intra-Cellular Therapies Inc.

www.intracellulartherapies.com

Latest From Intra-Cellular Therapies Inc.

Keeping Track: Amarin And Nektar Signal Delays, DBV Returns, And Provention Notches A BTD

The latest drug development news and highlights from our US FDA Performance Tracker.

Drug Review Complete Response Letters

Intra-Cellular's Lumateperone Brings Mixed Results In Bipolar Depression

Firm will discuss Phase III data with the US FDA, calling results from a successful Phase III monotherapy study robust despite second Phase III study's failure. Lumateperone is under review for schizophrenia, with a 27 September action date.

Clinical Trials Drug Approval Standards

Keeping Track: FDA Clears Motegrity And Second Herceptin Biosimilar, But Rebuffs SpecGx's Oxycodone

The latest drug development news and highlights from our US FDA Performance Tracker.
Drug Review Regulation

Priority Reviews At US FDA: From Third Quarter Spikes To A Third Quarter Trough

Priority review announcements saw significant dip in third quarter 2018, while they usually experience a spike during the period; breakthrough therapy designations remained in double digits.
Review Pathway Research & Development
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
  • Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Intra-Cellular Therapies Inc.
  • Senior Management
  • Sharon Mates, PhD, Chmn. & CEO
    Lawrence J Hineline, VP, Fin. & CFO
    Allen A Fienberg, PhD, VP, Bus. Dev.
    Robert E Davis, PhD, SVP, CSO
    Andrew Satlin, MD, EVP, CMO
    Mark Neumann, EVP, Chief Commercial Officer
  • Contact Info
  • Intra-Cellular Therapies Inc.
    Phone: (646) 440-9333
    430 East 29th St.
    Ste. 900
    New York, NY 10016
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register